,i  #aaith ,,congress  #ast ,session    
,h4 ,r4 #fghi  ,,in ,,the ,,house ,,of  
,,representatives  ,december #ag1       
#bjbe,mrs4 ,foushee 7for herself1 ,mrs4 
,mc,bath1 and ,mr4 ,johnson of ,georgia7
 introduced the following bill2 which   
was referred to the ,committee on the   
,judiciary  ,a ,,bill  ,to amend title  
#ah1 ,united ,states ,code1 to require  
the ,bureau of ,prisons to ensure the   
availability of opioid antagonists at   
,federal correctional facilities4  #a4  
,short title ,this ,act may be cited as 
the ,federal ,prisons ,naloxone ,access 
,act of #bjbe4  #b4 ,availability of    
opioid antagonists ,chapter #cjc of     
title #ah1 ,united ,states ,code1 is    
amended-- 7#a7 by adding at the end the 
following3  #djeb4 ,availability of     
opioid antagonists  7a7 ,in general ,the
 ,director of the ,bureau of ,prisons   
shall ensure that-- 7#a7 an adequate    
number of opioid antagonist kits are    
maintained at each correctional facility
 administered by the ,bureau1 and such  

kits are available in-- 7,a7 medical    
housing units2  7,b7 staff breakrooms2  
and  7,c7 visiting areas1 living        
quarters1 recreation spaces1 dining     
halls1 housing units1 work and program  
locations1 hallways1 corridor posts1    
security checkpoints1 any area where    
incarcerated people congregate1 and     
educational and religious areas2  7#b7  
that each such opioid antagonist kit is 
maintained appropriately1 including     
storage-- 7,a7 in appropriate conditions
 at room temperature and out of direct  
sunlight2 and  7,b7 in a secure area    
that is accessible to personnel of the  
facility2  7#c7 that incarcerated       
persons are able to access such opioid  
antagonist kits to administer to those  
who are overdosing2 and  7#d7 in the    
case of any opioid antagonist kit with  
an expiration date1 that such kit is    
regularly checked to determine if there 
is a need to replace it4  7b7 ,training 
,the ,director shall ensure that the    
personnel and incarcerated persons of   

each correctional facility administered 
by the ,bureau receive annual training  
from medical staff of the ,bureau of    
,prisons on the administration of opioid
 antagonists1 including guidance on     
recognizing any signs or symptoms of an 
opioid overdose4  7c7 ,documentation    
,the ,director shall ensure that1 with  
regard to each administration of an     
opioid antagonist at a correctional     
facility1 the following are recorded3   
7#a7 ,the location of the               
administration4  7#b7 ,the time of the  
administration4  7#c7 ,the name of the  
individual that the opioid antagonist   
was administered to4  7#d7 ,the name and
 title of the person that administered  
the opioid antagonist and the status of 
the individual to whom the opioid       
antagonist was administered4  7d7 ,no   
liability for administration ,no        
incarcerated person may be held liable  
for the administration of an opioid     
antagonist kit in good faith4  7e7      
,report ,the ,director of the ,bureau of

 ,prisons shall submit a report each    
year to ,congress detailing compliance  
with the requirements of this section1  
including-- 7#a7 the amount of opioid   
antagonists available at each           
correctional facility2  7#b7 the number 
of opioid overdoses at each such        
facility2  7#c7 the number of trainings 
under subsection 7b7 at each such       
facility2 and  7#d7 the number of       
expired opioid antagonist kits4  7f7    
,definitions ,in this section3 7#a7 ,the
 term opioid antagonist means a         
medication approved by the ,federal     
,food and ,drug ,administration that1   
when administered1 neutralizes in whole 
or in part the pharmacological effects  
of an opioid in the human body4  7#b7   
,the term opioid overdose prevention kit
 means a kit containing-- 7,a7 an opioid
 antagonist2 and  7,b7 a pamphlet or    
other written notice that provides      
guidance on how to recognize the signs  
or symptoms of an opioid overdose and   
identifies the steps to take in response

 to a suspected opioid overdose4  7#c7  
,the term personnel includes            
correctional officers1 medical staff1   
counselors1 and other employees of the  
,bureau of ,prisons4  7g7 ,authorization
 of appropriations ,there are authorized
 to be appropriated3 7#a7 for fiscal    
year #bjbf1 #f1jjj1jjj1 for training1   
purchase of opioid antagonists1 and the 
initial report2  7#b7 for each of fiscal
 years #bjbg and #bjbh1 #b1jjj1jjj1 for 
maintenance of opioid antagonist kits   
and training1 and for additional        
reporting on the effectiveness of the   
program4  2 and  7#b7 in the table of   
sections for such chapter1 by adding at 
the end the following3  #djeb4          
,availability of opioid antagonists4  4